CD24 and human carcinoma: Tumor biological aspects

Biomedicine and Pharmacotherapy

Volumn 59, Issue SUPPL. 2, 2005, Pages

  Lim, S C ^a  

^a Chosun University College of Medicine   (South Korea)

Author keywords

Cancer; CD24; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CD21 ANTIBODY; CD24 ANTIBODY; CD24 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; MESSENGER RNA; PADGEM PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN EXPRESSION; B LYMPHOCYTE; CANCER DIAGNOSIS; CANCER IMMUNOLOGY; CANCER INVASION; CARCINOMA; CELL INTERACTION; DOWN REGULATION; DRUG MECHANISM; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOPROLIFERATIVE DISEASE; METASTASIS; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVIEW;

EID: 33644531614     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(05)80076-9     Document Type: Article

References (33)

1. Aigner S., Ramos C.L., Hafezi-Moghadam A., Lawrence M.B., Friederichs J., Altevogt P., and Ley K. CD24 mediates rolling of breast carcinoma cells on P-selectin FASEB J 12 1998 1241 1251
2. Aigner S., Ruppert M., Hubbe M., Sammar M., Sthoeger Z., Butcher E.C., Vestweber D., and Altevogt P. Heat-stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin Int Immunol 7 1995 1557 1565
3. Benkerrou M., Jais J.P., Leblond V., Durandy A., Sutton L., Bordigoni P., Gamier J.L., Le Bidois J., Le Deist F., Blanche S., and Fischer A. Anti-B-cell monoclonal antibody treatment of severe post-transplant B-lympho proliferative disorder: prognostic factors and long-term outcome Blood 92 1998 3137 3147
4. Chappel M.S., Hough M.R., Mittel A., Takei F., Kay R., and Humphries R.K. Cross-linking the murine heat-stable antigen induces apoptosis in Bcell precursors and suppresses the anti-CD40-induced proliferation of mature resting B lymphocytes J Exp Med 184 1996 1638 1649
5. Fidler I.J. Critical factors in the biology of human cancer metastasis: 28th G.H.A. Clowes memorial award lecture Cancer Res 50 1990 6130 6318
6. Fischer A., Blanche S., Le Bidois J., Bordigoni P., Gamier J.L., Niaudet P., Morinet F., Le Deist F., Fischer A.M., and Griscelli C. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoprolifera tive syndrome following bone marrow and organ transplantation N Engl J Med 324 1991 1451 1456
7. Fogel M., Friederichs J., Zeller Y., Husar M., Smirnov A., Roitman L., Altevogt P., and Sthoeger Z.M. CD24 is a marker for human breast carcinoma Cancer Lett 143 1999 87 94
8. Friederichs J., Zeller Y., Hafezi-Moghadam A., Grone H.J., Ley K., and Altevogt P. The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells Cancer Res 60 2000 6714 6722
9. Gamier J.L., Stevenson G., Blanc-Brunat N., Touraine J.L., Milpied N., Leblond V., and Blay J.Y. Treatment of post-transplant lymphomas with anti-B-cell monoclonal antibodies. Recent results Cancer Res 159 2002 113 122
10. Jemal A., Thomas A., Murray T., and Thun M. Cancer statistics, 2002 CA Cancer J Clin 52 2002 23 47
11. Katayama A., Bandoh N., Kishibe K., Takahara M., Ogino T., Nonaka S., and Harabuchi Y. Expressions of matrix metalloproteinases in earlystage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis Clin Cancer Res 10 2004 634 640
12. Kim Y.J., Borsig L., Varki N.M., and Varki A. P-selectin deficiency attenuates tumor growth and metastasis Proc Natl Acad Sci USA 95 1998 9325 9330
13. Kleene R., Yang H., Kutsche M., and Schachner M. The neural recognition molecule L1 is a sialic acid-binding lectin for CD24, which induces promotion and inhibition of neurite outgrowth J Biol Chem 276 2001 21656 21663
14. Krause T., and Turner G.A. Are selectins involved in metastasis? Clin Exp Metastasis 17 1999 183 192
15. Kristiansen G., Denkert C., Schluns K., Dahl E., Pilarsky C., and Hauptmann S. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival Am J Pathol 161 2002 1215 1221
16. Kristiansen G., Pilarsky C., Pervan J., Sturzebecher B., Stephan C., Jung K., Leoning S., Rosenthal A., and Dietel M. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer Prostate 58 2004 183 192
17. Kristiansen G., Schluns K., Yonwei Y., Denkert C., Dietel M., and Petersen I. CD24 is an independent prognostic marker of survival in non-small cell lung cancer patients Br J Cancer 88 2003 231 236
18. Kristiansen G., Winzer K.J., Mayordomo E., Bellach J., Schluns K., Denkert C., Dahl E., Pilarsky C., Altevogt P., Guski H., and Dietel M. CD24 expression is a new prognostic marker in breast cancer Clin Cancer Res 9 2003 4906 4913
19. Lasky L.A. Selectin-carbohydrate interactions and the initiation of the inflammatory response Annu Rev Biochem 64 1995 113 139
20. Liu Y., Jones B., Aruffo A., Sullivan K.M., Linsley P.S., and Janeway C.A. Jr. Heat-stable antigen is a co-stimulatory molecule for CD4 T-cell growth J Exp Med 175 1992 435 445
21. Mannori G., Crottet P., Cecconi O., Hanasaki K., Aruffo A., Nelson R.M., Varki A., and Bevilacqua M.P. Differential colon cancer cell adhesion to E-, P-, and L-selection: role of mucin-type glycoproteins Cancer Res 55 1995 4425 4431
22. McEver R.P. GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium J Cell Biochem 45 1991 156 161
23. Mori I., Yang Q., and Kakudo K. Predictive and prognostic markers for invasive breast cancer Pathol Int 52 2002 186 194
24. x antigen correlaets with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study Cancer Res 53 1993 3632 3637
25. Negrier S., Perol D., Menetrier-Caux C., Escudier B., Pallardy M., Ravaud A., Douillard J.Y., Chevreau C., Lasset C., and Blay J.Y. Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6 J Clin Oncol 15 2004 2371 2378
26. Nielsen P.J., Lorenz B., Muller A.M., Wenger R.H., Brombacher F., Simon M., von der Weid T., Langhrone W.J., Mossmann H., and Kohler G. Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice Blood 89 1997 1058 1067
27. Nowacki M.P., Janik P., and Nowacki P.M. Inflammation and metastases Med Hypotheses 47 1996 193 196
28. Pirruccello S.J., and LeBien T.W. The human B-cell-associated antigen CD24 is a single chain sialoglycoprotein J Immunolol 136 1986 3779 3784
29. Schindelmann S., Windisch J., Grundmann R., Kreienberg R., Zeillinger R., and Deissler H. Expression profiling of mammary carcinoma cell lines: correlation of in vitro invasiveness with expression of CD24 Tumor Biol 23 2002 139 145
30. Senner V., Sturm A., Baur I., Schrell U.H., Distel L., and Paulus W. CD24 promotes invasion of glioma cells in vivo J Neuropathol Exp Neurol 58 1999 795 802
31. Stefanova I., Horejsi V., Ansotegui I.J., Knapp W., and Stockinger H. GPI-anchored cell surface molecules complexed to protein tyrosine kinases Science 254 1991 1016 1019
32. Vestweber D., and Blanks J.E. Mechanisms that regulate the function of the selectins and their ligands Physiol Rev 79 1999 181 213
33. Yang J., Furie B.C., and Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction Thromb Haemost 81 1999 1 7